药物基因组学
经济评价
估价(财务)
成本-效用分析
心理干预
支付意愿
计算机科学
风险分析(工程)
成本效益
医学
经济
药理学
财务
病理
精神科
微观经济学
作者
Vasileios Fragoulakis,Margarita-Ioanna Koufaki,Korina Tzerefou,Konstantinos Koufou,George P. Patrinos,Christina Mitropoulou
出处
期刊:Pharmacogenomics
[Future Medicine]
日期:2024-01-01
卷期号:25 (2): 79-95
标识
DOI:10.2217/pgs-2023-0221
摘要
An increasing number of economic evaluations are published annually investigating the economic effectiveness of pharmacogenomic (PGx) testing. This work was designed to provide a comprehensive summary of the available utility methods used in cost-effectiveness/cost-utility analysis studies of PGx interventions. A comprehensive review was conducted to identify economic analysis studies using a utility valuation method for PGx testing. A total of 82 studies met the inclusion criteria. A majority of studies were from the USA and used the EuroQol-5D questionnaire, as the utility valuation method. Cardiovascular disorders was the most studied therapeutic area while discrete-choice studies mainly focused on patients' willingness to undergo PGx testing. Future research in applying other methodologies in PGx economic evaluation studies would improve the current research environment and provide better results.
科研通智能强力驱动
Strongly Powered by AbleSci AI